Examkin

Soru

Zorluk: ZorImmunologic and Inflammatory Processes

While picnicking at a local park, a 28-year-old man sustains multiple bee stings and rapidly develops a diffuse urticarial rash, lip swelling, and severe shortness of breath. Paramedics transport him to the emergency department. Upon arrival, he is in profound respiratory distress with audible stridor. Vital signs show a heart rate of 135/min, blood pressure of 75/40 mm Hg, and oxygen saturation of 89% on room air. Lung auscultation reveals diffuse expiratory wheezing. A severe type I immunoglobulin E (IgE)-mediated hypersensitivity reaction is recognized.

Arrange the following therapeutic interventions in the most appropriate chronological sequence for the step-wise management of this patient's systemic immunologic reaction.

  1. 1Administer the first dose of intramuscular epinephrine into the anterolateral thigh
  2. 2Administer rapid intravenous crystalloid fluid boluses for severe hypotension
  3. 3Administer a second dose of intramuscular epinephrine if symptoms persist after 5 to 15 minutes
  4. 4Initiate a continuous intravenous epinephrine infusion for refractory shock
  5. 5Administer intravenous methylprednisolone and diphenhydramine to prevent biphasic reactions

Cevap

The correct sequence for managing severe anaphylactic shock is: 1) Initial intramuscular epinephrine, 2) Intravenous fluid resuscitation, 3) Repeat intramuscular epinephrine, 4) Intravenous epinephrine infusion, and 5) Adjunctive steroids and antihistamines.
The precise immunologic timeline of anaphylaxis requires rapid reversal of mast cell degranulation effects. Intramuscular epinephrine provides the optimal balance of rapid onset and safety. Fluid resuscitation treats the subsequent distributive shock. Escalating doses (repeat IM, then IV infusion) meet the ongoing cardiovascular demand. Finally, slower-acting agents (steroids/antihistamines) are given to blunt the late-phase inflammatory response.

Adım Adım Çözüm

1
Administer initial intramuscular epinephrine.
Epinephrine binds to alpha-1, beta-1, and beta-2 receptors, counteracting the immunologic cascade by inducing vasoconstriction and bronchodilation.
This is the single most effective intervention for anaphylaxis and must be given immediately upon recognition to prevent fatal cardiovascular collapse or airway obstruction.
2
Provide aggressive volume resuscitation.
Intravenous crystalloid boluses are administered rapidly.
Systemic mast cell degranulation causes massive capillary leak and distributive shock, requiring large volumes of fluids to maintain preload while epinephrine exerts its effects.
3
Re-evaluate and administer a second dose of intramuscular epinephrine.
A repeat IM dose is given if the patient remains in shock or severe distress after 5 to 15 minutes.
Up to 20% of anaphylaxis cases require more than one dose of IM epinephrine due to severe ongoing mediator release from the type I hypersensitivity reaction.
4
Escalate to a continuous vasopressor infusion.
An intravenous epinephrine infusion is started.
When anaphylaxis is refractory to repeated IM epinephrine and adequate fluid boluses, a titratable IV infusion is necessary to maintain systemic vascular resistance.
5
Provide adjunctive immunomodulators.
Glucocorticoids (methylprednisolone) and H1-antihistamines (diphenhydramine) are administered.
These medications do not treat the acute life-threatening symptoms but help control cutaneous manifestations and may decrease the risk of a biphasic immunologic reaction 4 to 12 hours later.

Anahtar Kavram

The acute management of anaphylaxis follows a strict stepwise progression prioritizing interventions that immediately reverse life-threatening cardiopulmonary compromise (IM epinephrine, IV fluids), followed by escalation for refractory cases (IV epinephrine infusion), and finally adjunctive immunomodulators (steroids, antihistamines) to prevent delayed biphasic reactions.
Bu soruyu puanla

Konular

Immunologic and Inflammatory Processes

Bu konudan daha fazla soru